Search results
Apr 8, 2024 · Adalat (nifedipine) is used to treat hypertension (high blood pressure) and angina (chest pain). Includes Adalat side effects, interactions and indications.
Apr 13, 2023 · Adalat (nifedipine) is a calcium channel blocker drug that relaxes (widens) blood vessels (veins and arteries), which makes it easier for the heart to pump and reduces its workload and is used to lower high blood pressure ( hypertension) and to treat chest pain ( angina ).
Aug 24, 2010 · Adalat CC tablets consist of an external coat and an internal core. Both contain nifedipine, the coat as a slow release formulation and the core as a fast release formulation. Adalat CC tablets...
What is NIFEdipine (Eqv-Adalat CC)? NIFEdipine (Eqv-Adalat CC) is used in adults to treat hypertension (high blood pressure) or angina (chest pain). NIFEdipine (Eqv-Adalat CC) capsules should not be used to treat hypertension (high blood pressure). NIFEdipine (Eqv-Adalat CC) may also be used for purposes not listed in this medication guide.
Find patient medical information for Adalat CC oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Sep 25, 2023 · Detailed dosage guidelines and administration information for Adalat CC (nifedipine). Includes dose adjustments, warnings and precautions.
Find everything you need to know about Nifedipine (Nifedipine (Eqv-Adalat CC)), including what it is used for, warnings, reviews, side effects, and interactions.
Feb 17, 2020 · Adalat CC, Afeditab CR: Administer on an empty stomach (per manufacturer). Other extended release products may not have this recommendation; consult product labeling. Dietary Considerations. Avoid grapefruit juice with all products.
Find medical information for Adalat CC on epocrates online, including its dosing, contraindications, drug interactions, and pill pictures.
Mar 26, 1992 · ADALAT XL (nifedipine extended-release tablets) is indicated in the management of chronic stable angina (effort-associated angina) without evidence of vasospasm in patients who remain symptomatic despite adequate doses of beta blockers and/or nitrates, or who cannot tolerate these agents.
